Clinical Laserthermia Systems AB (publ) (CLS-B) — Tangible Net Worth Ratio
Clinical Laserthermia Systems AB (publ) (CLS-B) has a Tangible Net Worth Ratio of 81.2% as of March 2026. This metric is calculated by deducting intangible assets (Skr10.79 Million) from net assets (Skr57.52 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. See CLS-B net assets for net asset value and shareholders' equity analysis.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Clinical Laserthermia Systems AB (publ) Tangible Net Worth Ratio (2008–2025)
This chart shows how Clinical Laserthermia Systems AB (publ)'s Tangible Net Worth Ratio has changed across 18 annual periods from 2008 to 2025. As of March 2026, the ratio stands at 81.2%, reflecting net assets of Skr57.52 Million with intangible assets of Skr10.79 Million SEK. Also explore CLS-B year-over-year net asset growth to track the company's year-over-year net asset growth rate.
Annual Tangible Net Worth Ratio for Clinical Laserthermia Systems AB (publ) (2008–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Clinical Laserthermia Systems AB (publ) from 2008 to 2025, covering 18 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. For the full company profile including market capitalisation, see CLS-B stock market capitalisation.
| Year | Tangible NW Ratio | Net Assets (SEK) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 83.0% | Skr66.48 Million | Skr11.29 Million | Skr76.49 Million | ▲ +16.3 pp |
| 2024 | 66.7% | Skr65.69 Million | Skr21.85 Million | Skr78.56 Million | ▲ +10.1 pp |
| 2023 | 56.6% | Skr43.53 Million | Skr18.88 Million | Skr57.73 Million | ▲ +181.2 pp |
| 2022 | -124.6% | Skr7.87 Million | Skr17.66 Million | Skr49.51 Million | ▼ -132.1 pp |
| 2021 | 7.5% | Skr21.18 Million | Skr19.59 Million | Skr66.74 Million | ▲ +60.1 pp |
| 2020 | -52.6% | Skr13.93 Million | Skr21.25 Million | Skr44.40 Million | ▲ +186.3 pp |
| 2019 | -238.9% | Skr7.00 Million | Skr23.71 Million | Skr38.67 Million | ▼ -286.6 pp |
| 2018 | 47.7% | Skr49.81 Million | Skr26.05 Million | Skr58.02 Million | ▲ +19.6 pp |
| 2017 | 28.1% | Skr33.00 Million | Skr23.72 Million | Skr44.94 Million | ▲ +45.5 pp |
| 2016 | -17.4% | Skr17.06 Million | Skr20.03 Million | Skr27.30 Million | ▼ -22.4 pp |
| 2015 | 5.0% | Skr19.46 Million | Skr18.49 Million | Skr22.27 Million | ▼ -42.5 pp |
| 2014 | 47.5% | Skr31.58 Million | Skr16.59 Million | Skr36.95 Million | ▲ +1.8 pp |
| 2013 | 45.7% | Skr26.09 Million | Skr14.18 Million | Skr29.20 Million | ▲ +14.3 pp |
| 2012 | 31.4% | Skr17.09 Million | Skr11.73 Million | Skr20.06 Million | ▲ +23.1 pp |
| 2011 | 8.2% | Skr10.83 Million | Skr9.94 Million | Skr13.01 Million | ▼ -13.2 pp |
| 2010 | 21.5% | Skr10.36 Million | Skr8.14 Million | Skr11.76 Million | ▲ +15.7 pp |
| 2009 | 5.8% | Skr6.63 Million | Skr6.24 Million | Skr8.20 Million | ▼ -9.7 pp |
| 2008 | 15.5% | Skr3.68 Million | Skr3.11 Million | Skr5.52 Million | — |